Skip to main content

Proteome Sciences Pens Research Agreement With Undisclosed Dx Shop

NEW YORK (GenomeWeb News) – Proteome Sciences signed its fourth research license agreement with an unnamed global diagnostics company to evaluate its biomarkers for stroke, the company said today.
The biomarkers were discovered and validated through the company’s ProteoSHOP platform.
Financial details were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.